Skip to main content

Design of polyPEPTIdes diblock copolymers as emulsifiers to produce safe, controlled and reliable novel stimuli-responsive nanoCAPSules for skin care applications

Ziel

PeptiCaps aims at producing and validating a new family of stimuli-responsive nanocapsules able to encapsulate efficiently and protect specific active ingredients for skin care application. Those nanocapsules will be assembled by nanoemulsion technique using amphiphilic and biocompatible polypeptides diblock copolymers with one hydrophilic poly(ethylene glycol) block and one hydrophobic polypeptide block. Adjustment of the length of each block to finely tune the hydrophilic/Lipophilic balance of the macroemulsifier will allow the encapsulation of either hydrophobic or hydrophilic active ingredients. In addition, polypeptides block will be specifically designed to respond to changes in pH and the presence of enzyme occurring for the skin conditions targeted to allow a triggered release of the active ingredient. After scaling-up selected macroemulsifiers under GMP-like process, two manufacturing processes will be used for the production of the nanocapsules, i.e. high-pressure homogenizer and tubular flow contactor. The most promising process will be selected to produce selected nanocapsules. Physico-chemical properties and (eco)toxicity of the nanocapsules will be extensively characterised using techniques and protocols recommended by the EU Cosmetic regulation to establish their risk and safety assessment. The advantages of safe nanocapsules from PeptiCaps will be demonstrated on validated relevant skin models for each application. All results obtained will be gathered to constitute a Dossier for the validation of the nanocapsules as cosmetic product by the authorities. In addition, PeptiCaps will actively participate to the standardization for nano-safety by developing software to predict the toxicity of nanomaterials (CORAL). Finally, a business plan will be elaborated for the commercialization of PeptiCaps nanocapsules for all cosmetic applications as well as other markets (dermatology and food) to ensure full exploitation of the PeptiCaps technology.

Aufforderung zur Vorschlagseinreichung

H2020-NMP-PILOTS-2015
Andere Projekte für diesen Aufruf anzeigen

Koordinator

FUNDACION CIDETEC
Adresse
Paseo Miramon 196 Parque Tecnologico De Miramon
20014 San Sebastian
Spanien
Aktivitätstyp
Research Organisations
EU-Beitrag
€ 895 000

Beteiligte (8)

UNIVERSITE DE BORDEAUX
Frankreich
EU-Beitrag
€ 417 278,75
Adresse
Place Pey Berland 35
33000 Bordeaux
Aktivitätstyp
Higher or Secondary Education Establishments
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA
Spanien
EU-Beitrag
€ 460 656,25
Adresse
Barrio Sarriena S N
48940 Leioa
Aktivitätstyp
Higher or Secondary Education Establishments
AHAVA DEAD SEA LABORATORIES LTD
Israel
EU-Beitrag
€ 371 522,50
Adresse
Arava Street 1
70150 Airport City
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
POLYPEPTIDE THERAPEUTIC SOLUTIONS SOCIEDAD LIMITADA
Spanien
EU-Beitrag
€ 482 875
Adresse
Parque Tecnologico Calle Benjamin Franklin 19
46980 Valencia
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITE LYON 1 CLAUDE BERNARD
Frankreich
EU-Beitrag
€ 419 093,75
Adresse
Boulevard Du 11 Novembre 1918 Num43
69622 Villeurbanne Cedex
Aktivitätstyp
Higher or Secondary Education Establishments
ANGEL CONSULTING SAS DI MATTEO ZANOTTI RUSSO & C
Italien
EU-Beitrag
€ 147 500
Adresse
Via San Senatore 14
20122 Milano
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Italien
EU-Beitrag
€ 435 500
Adresse
Via Mario Negri 2
20156 Milano
Aktivitätstyp
Research Organisations
SPINVERSE OY
Finnland
EU-Beitrag
€ 222 867,50
Adresse
Keilasatama 5
02150 Espoo
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)